Fortress Biotech (FBIO) Closes Sale of Checkpoint Therapeutics May 30, 2025 10:48AM
Partex and Fortress Biotech (FBIO) Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform Mar 17, 2025 08:56AM
Fortress Biotech (FBIO) and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 Jan 6, 2025 08:01AM
Fortress Biotech (FBIO) Prices 3.94M Sharee Offering at $1.65/sh Sep 20, 2024 08:31AM
Fortress Biotech (FBIO) Reduces Total Debt, Enters $35M Term Loan with Oaktree with Maturity in 2027 Jul 25, 2024 08:31AM